Daiichi Sankyo Company, Limited: Revision history

28 July 2023

• curprev 10:2010:20, 28 July 2023‎ Eyec talk contribs‎ m 36,281 bytes −26‎ No edit summary undo Tag: Visual edit
• curprev 09:3609:36, 28 July 2023‎ MishaG talk contribs‎ m 36,307 bytes +246‎ →‎Dato-DXd undo Tag: Visual edit
• curprev 09:3109:31, 28 July 2023‎ MishaG talk contribs‎ m 36,061 bytes −72‎ →‎3ADC Conclusion undo Tag: Visual edit
• curprev 09:2909:29, 28 July 2023‎ MishaG talk contribs‎ m 36,133 bytes −8‎ →‎3ADC Conclusion undo Tag: Visual edit
• curprev 09:2609:26, 28 July 2023‎ MishaG talk contribs‎ 36,141 bytes +3‎ →‎HER3-DXd undo Tag: Visual edit
• curprev 08:1308:13, 28 July 2023‎ Eyec talk contribs‎ 36,138 bytes +2,162‎ No edit summary undo Tag: Visual edit
• curprev 06:5706:57, 28 July 2023‎ Eyec talk contribs‎ m 33,976 bytes −790‎ No edit summary undo Tag: Visual edit
• curprev 06:3206:32, 28 July 2023‎ MishaG talk contribs‎ 34,766 bytes 0‎ →‎Leadership undo Tag: Visual edit
• curprev 06:3106:31, 28 July 2023‎ MishaG talk contribs‎ 34,766 bytes +78‎ →‎Leadership undo Tag: Visual edit
• curprev 06:2306:23, 28 July 2023‎ MishaG talk contribs‎ 34,688 bytes +1,033‎ →‎Risk undo Tag: Visual edit
• curprev 06:1106:11, 28 July 2023‎ MishaG talk contribs‎ 33,655 bytes +1‎ →‎Leadership undo Tag: Visual edit
• curprev 06:1006:10, 28 July 2023‎ MishaG talk contribs‎ 33,654 bytes +910‎ →‎Board Of Directors: undo Tag: Visual edit
• curprev 06:1006:10, 28 July 2023‎ MishaG talk contribs‎ 32,744 bytes −911‎ →‎Board Of Directors: undo
• curprev 06:0906:09, 28 July 2023‎ MishaG talk contribs‎ 33,655 bytes +1‎ →‎Board Of Directors: undo Tag: Visual edit
• curprev 06:0706:07, 28 July 2023‎ MishaG talk contribs‎ 33,654 bytes +6,201‎ →‎Created shared value with stakeholders undo Tag: Visual edit
• curprev 04:5204:52, 28 July 2023‎ Eyec talk contribs‎ m 27,453 bytes +591‎ →‎Financials undo Tag: Visual edit
• curprev 04:3304:33, 28 July 2023‎ Eyec talk contribs‎ 26,862 bytes +4,205‎ No edit summary undo Tag: Visual edit
• curprev 04:2004:20, 28 July 2023‎ MishaG talk contribs‎ 22,657 bytes −72‎ →‎Created shared value with stakeholders undo Tag: Visual edit
• curprev 04:1904:19, 28 July 2023‎ 94.174.127.214 talk‎ 22,729 bytes +212‎ →‎Created shared value with stakeholders undo Tag: Visual edit

27 July 2023

• curprev 23:0723:07, 27 July 2023‎ 94.174.127.214 talk‎ 22,517 bytes +3,436‎ →‎Products undo Tag: Visual edit
• curprev 20:3920:39, 27 July 2023‎ MishaG talk contribs‎ 19,081 bytes +160‎ →‎HER3-DXd undo Tag: Visual edit
• curprev 05:4505:45, 27 July 2023‎ Eyec talk contribs‎ 18,921 bytes −287‎ →‎Investment Thesis undo Tag: Visual edit
• curprev 05:4405:44, 27 July 2023‎ Eyec talk contribs‎ 19,208 bytes +1,953‎ →‎Catalysts undo Tag: Visual edit

23 July 2023

• curprev 18:3618:36, 23 July 2023‎ MishaG talk contribs‎ 17,255 bytes +5,386‎ →‎Company Overview and Breakdown undo Tag: Visual edit
• curprev 14:1214:12, 23 July 2023‎ MishaG talk contribs‎ 11,869 bytes +1,297‎ →‎Company Overview and Breakdown undo Tag: Visual edit
• curprev 13:2213:22, 23 July 2023‎ MishaG talk contribs‎ 10,572 bytes +387‎ →‎Company Overview and Breakdown undo Tag: Visual edit
• curprev 10:2810:28, 23 July 2023‎ 94.174.127.214 talk‎ 10,185 bytes +1,802‎ →‎Macro Analysis undo Tag: Visual edit
• curprev 00:5500:55, 23 July 2023‎ MishaG talk contribs‎ 8,383 bytes +477‎ →‎Macro Analysis undo Tag: Visual edit: Switched

22 July 2023

• curprev 13:5213:52, 22 July 2023‎ Manos talk contribs‎ 7,906 bytes +2,488‎ No edit summary undo Tag: Visual edit: Switched

20 July 2023

• curprev 11:5811:58, 20 July 2023‎ Eyec talk contribs‎ m 5,418 bytes +159‎ →‎Financials undo Tag: Visual edit
• curprev 11:5411:54, 20 July 2023‎ Eyec talk contribs‎ 5,259 bytes +21‎ →‎Financials undo Tag: Visual edit
• curprev 11:5311:53, 20 July 2023‎ 95.149.161.164 talk‎ 5,238 bytes −842‎ No edit summary undo Tag: Visual edit
• curprev 11:5011:50, 20 July 2023‎ Eyec talk contribs‎ m 6,080 bytes +4,063‎ uploaded initial draft undo Tag: Visual edit

19 August 2022

• curprev 20:5720:57, 19 August 2022‎ 95.149.241.133 talk‎ 2,017 bytes +11‎ No edit summary undo Tag: Visual edit: Switched

12 August 2022

• curprev 15:5715:57, 12 August 2022‎ 109.180.50.163 talk‎ 2,006 bytes +15‎ No edit summary undo Tag: Visual edit: Switched

28 July 2022

• curprev 07:2907:29, 28 July 2022‎ Chris talk contribs‎ 1,991 bytes +1,991‎ Created page with "Daiichi Sankyo Company, Limited researches and develops, manufactures, imports, markets, and sells pharmaceutical products worldwide. The company offers trastuzumab deruxtecan, an anti-cancer agent and anti-HER2 antibody drug conjugate; mirogabalin for pain treatment; teneligliptin/canagliflozin for type 2 diabetes mellitus treatment; lacosamide anti-epileptic agent; prasugrel, an antiplatelet agent; denosumab for osteoporosis and bone disorders; teneligliptin for type 2..." Tag: Visual edit